![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Provides Update on Barda Development Proposal
January 23, 2014 07:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Jan. 23, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Biomedical Advanced Research and Development Authority ("BARDA") has terminated...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Announces $7 Million At-The-Market Registered Direct Offering
January 14, 2014 09:05 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that it has entered into definitive agreements with two institutional investors to purchase an...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Announces Departure of Jean Viallet to Assume Oncology Development Leadership Role at Leading Biopharmaceutical Company
December 18, 2013 10:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported that Chief Development Officer, Jean Viallet, MD will leave the Company to assume an oncology...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs to Present at Oppenheimer 24th Annual Healthcare Conference
December 03, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company is scheduled to present at the Oppenheimer & Co. 24th Annual Healthcare...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs and Incuron Announce Poster Presentation at Society of Neuro-Oncology Meeting
November 21, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Nov. 21, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Reports Third Quarter 2013 Financial Results and Development Progress
November 06, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the third quarter and nine-month periods ended...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs to Report Third Quarter 2013 Financial Results and Provide Operational Update on November 6
October 29, 2013 08:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 29, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on November 6, 2013, it will report its financial results for the third quarter and...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Panacela Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Mobilan; Announces Appointment of Michael Fonstein as CEO and President
October 23, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that Panacela Labs, Inc., a majority-owned subsidiary of CBLI, has entered into a contract valued...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Optimizes Operational Focus on Clinical Development
October 18, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 18, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today that because of maturation of its development pipeline and a reduced need for certain services,...
![Cleveland BioLabs, Inc. Logo](/news-release/logo/213507/0/213507.jpg?lastModified=12%2F10%2F2016%2004%3A31%3A45&size=2)
Cleveland BioLabs Signs Contract With Russian Ministry of Industry and Trade for Clinical Development of Entolimod (CBLB502)
October 16, 2013 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that its wholly-owned Russian subsidiary, BioLab 612, LLC, has entered into a three-year contract...